The number of confirmed cases of the coronavirus illness COVID-19 world-wide climbed above 39.4 million on Saturday, a day after a clinical trial found one therapy believed to be promising as a treatment to have no effect on mortality in hospitalized patients.
The trial, conducted by the World Health Organization, found that Gilead Sciences Inc.’s
remdesivir, as well as hydroxychloroquine, and AbbVie’s
lopinavir/ritonavir and interferon had “little or no effect” on overall mortality, ventilation, and length of hospital stay among 11,330 participating patients.
Results were presented in a preprint,…